Aardvark Therapeutics Rings the Closing Bell

About This Event

Aardvark Therapeutics, Inc. (Nasdaq: AARD), a clinical-stage biopharmaceutical company developing novel, small molecule therapeutics for the treatment of metabolic disease visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Tien Lee, M.D., CEO & Founder, rings the Closing Bell. 

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore